Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose tranexamic acid for craniosynostosis surgery
2013-001056-35Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Craniosynostosis (2 arms), sponsored by Istituto Giannina Gaslini. Primary endpoint: Estimated volume of blood lost. Started Sep 2014; status: active.
02
Drugs
tranexamic acid
03
Conditions
Craniosynostosis
Beyond the preview
Go deeper on 2013-001056-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001056-35.